BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22228101)

  • 1. Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer.
    Tang W; Fu YP; Figueroa JD; Malats N; Garcia-Closas M; Chatterjee N; Kogevinas M; Baris D; Thun M; Hall JL; De Vivo I; Albanes D; Porter-Gill P; Purdue MP; Burdett L; Liu L; Hutchinson A; Myers T; Tardón A; Serra C; Carrato A; Garcia-Closas R; Lloreta J; Johnson A; Schwenn M; Karagas MR; Schned A; Black A; Jacobs EJ; Diver WR; Gapstur SM; Virtamo J; Hunter DJ; Fraumeni JF; Chanock SJ; Silverman DT; Rothman N; Prokunina-Olsson L
    Hum Mol Genet; 2012 Apr; 21(8):1918-30. PubMed ID: 22228101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer risk.
    Selinski S; Lehmann ML; Blaszkewicz M; Ovsiannikov D; Moormann O; Guballa C; Kress A; Truss MC; Gerullis H; Otto T; Barski D; Niegisch G; Albers P; Frees S; Brenner W; Thüroff JW; Angeli-Greaves M; Seidel T; Roth G; Volkert F; Ebbinghaus R; Prager HM; Bolt HM; Falkenstein M; Zimmermann A; Klein T; Reckwitz T; Roemer HC; Hartel M; Weistenhöfer W; Schöps W; Rizvi SA; Aslam M; Bánfi G; Romics I; Ickstadt K; Hengstler JG; Golka K
    Arch Toxicol; 2012 Sep; 86(9):1369-78. PubMed ID: 22532026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and replication of the interplay of four genetic high-risk variants for urinary bladder cancer.
    Selinski S; Blaszkewicz M; Ickstadt K; Gerullis H; Otto T; Roth E; Volkert F; Ovsiannikov D; Moormann O; Banfi G; Nyirady P; Vermeulen SH; Garcia-Closas M; Figueroa JD; Johnson A; Karagas MR; Kogevinas M; Malats N; Schwenn M; Silverman DT; Koutros S; Rothman N; Kiemeney LA; Hengstler JG; Golka K
    Carcinogenesis; 2017 Dec; 38(12):1167-1179. PubMed ID: 29028944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium.
    Strassburg CP; Nguyen N; Manns MP; Tukey RH
    Mol Pharmacol; 1998 Oct; 54(4):647-54. PubMed ID: 9765507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.
    Rothman N; Garcia-Closas M; Chatterjee N; Malats N; Wu X; Figueroa JD; Real FX; Van Den Berg D; Matullo G; Baris D; Thun M; Kiemeney LA; Vineis P; De Vivo I; Albanes D; Purdue MP; Rafnar T; Hildebrandt MA; Kiltie AE; Cussenot O; Golka K; Kumar R; Taylor JA; Mayordomo JI; Jacobs KB; Kogevinas M; Hutchinson A; Wang Z; Fu YP; Prokunina-Olsson L; Burdett L; Yeager M; Wheeler W; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Johnson A; Schwenn M; Karagas MR; Schned A; Andriole G; Grubb R; Black A; Jacobs EJ; Diver WR; Gapstur SM; Weinstein SJ; Virtamo J; Cortessis VK; Gago-Dominguez M; Pike MC; Stern MC; Yuan JM; Hunter DJ; McGrath M; Dinney CP; Czerniak B; Chen M; Yang H; Vermeulen SH; Aben KK; Witjes JA; Makkinje RR; Sulem P; Besenbacher S; Stefansson K; Riboli E; Brennan P; Panico S; Navarro C; Allen NE; Bueno-de-Mesquita HB; Trichopoulos D; Caporaso N; Landi MT; Canzian F; Ljungberg B; Tjonneland A; Clavel-Chapelon F; Bishop DT; Teo MT; Knowles MA; Guarrera S; Polidoro S; Ricceri F; Sacerdote C; Allione A; Cancel-Tassin G; Selinski S; Hengstler JG; Dietrich H; Fletcher T; Rudnai P; Gurzau E; Koppova K; Bolick SC; Godfrey A; Xu Z; Sanz-Velez JI; D García-Prats M; Sanchez M; Valdivia G; Porru S; Benhamou S; Hoover RN; Fraumeni JF; Silverman DT; Chanock SJ
    Nat Genet; 2010 Nov; 42(11):978-84. PubMed ID: 20972438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refining the UGT1A haplotype associated with irinotecan-induced hematological toxicity in metastatic colorectal cancer patients treated with 5-fluorouracil/irinotecan-based regimens.
    Lévesque E; Bélanger AS; Harvey M; Couture F; Jonker D; Innocenti F; Cecchin E; Toffoli G; Guillemette C
    J Pharmacol Exp Ther; 2013 Apr; 345(1):95-101. PubMed ID: 23386248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis.
    Iida K; Itoh K; Kumagai Y; Oyasu R; Hattori K; Kawai K; Shimazui T; Akaza H; Yamamoto M
    Cancer Res; 2004 Sep; 64(18):6424-31. PubMed ID: 15374950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of AhR signaling pathway is associated with the down-regulation of UDP-glucuronosyltransferases during BBN-induced urinary bladder carcinogenesis in mice.
    Iida K; Mimura J; Itoh K; Ohyama C; Fujii-Kuriyama Y; Shimazui T; Akaza H; Yamamoto M
    J Biochem; 2010 Mar; 147(3):353-60. PubMed ID: 19880377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis.
    Izumi K; Zheng Y; Hsu JW; Chang C; Miyamoto H
    Mol Carcinog; 2013 Feb; 52(2):94-102. PubMed ID: 22086872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of Hepatic UDP glucuronosyltransferase 1A splice variant expression and correlation of UDP glucuronosyltransferase 1A1 variant expression with glucuronidation activity.
    Jones NR; Sun D; Freeman WM; Lazarus P
    J Pharmacol Exp Ther; 2012 Sep; 342(3):720-9. PubMed ID: 22661630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functional variant in TP63 at 3q28 associated with bladder cancer risk by creating an miR-140-5p binding site.
    Wang M; Du M; Ma L; Chu H; Lv Q; Ye D; Guo J; Gu C; Xia G; Zhu Y; Ding Q; Yuan L; Fu G; Tong N; Qin C; Yin C; Xu J; Zhang Z
    Int J Cancer; 2016 Jul; 139(1):65-74. PubMed ID: 26695686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue.
    Strassburg CP; Oldhafer K; Manns MP; Tukey RH
    Mol Pharmacol; 1997 Aug; 52(2):212-20. PubMed ID: 9271343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants in urinary bladder cancer: collective power of the "wimp SNPs".
    Golka K; Selinski S; Lehmann ML; Blaszkewicz M; Marchan R; Ickstadt K; Schwender H; Bolt HM; Hengstler JG
    Arch Toxicol; 2011 Jun; 85(6):539-54. PubMed ID: 21380501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UDP-glucuronosyltransferase polymorphisms affect diethylnitrosamine-induced carcinogenesis in humanized transgenic mice.
    Landerer S; Kalthoff S; Paulusch S; Strassburg CP
    Cancer Sci; 2020 Nov; 111(11):4266-4275. PubMed ID: 32860300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluid intake, genetic variants of UDP-glucuronosyltransferases, and bladder cancer risk.
    Wang J; Wu X; Kamat A; Barton Grossman H; Dinney CP; Lin J
    Br J Cancer; 2013 Jun; 108(11):2372-80. PubMed ID: 23632476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UGT1A polymorphisms associated with worse outcome in colorectal cancer patients treated with irinotecan-based chemotherapy.
    Yu Q; Zhang T; Xie C; Qiu H; Liu B; Huang L; Peng P; Feng J; Chen J; Zang A; Yuan X
    Cancer Chemother Pharmacol; 2018 Jul; 82(1):87-98. PubMed ID: 29728798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UGT1A6 polymorphisms modulated lung cancer risk in a Chinese population.
    Kua LF; Ross S; Lee SC; Mimura K; Kono K; Goh BC; Yong WP
    PLoS One; 2012; 7(8):e42873. PubMed ID: 22912755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gilbert syndrome redefined: a complex genetic haplotype influences the regulation of glucuronidation.
    Ehmer U; Kalthoff S; Fakundiny B; Pabst B; Freiberg N; Naumann R; Manns MP; Strassburg CP
    Hepatology; 2012 Jun; 55(6):1912-21. PubMed ID: 22213127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UGT1A1, UGT1A6 and UGT1A7 genetic analysis: repercussion for irinotecan pharmacogenetics in the São Miguel Island Population (Azores, Portugal).
    Pacheco PR; Brilhante MJ; Ballart C; Sigalat F; Polena H; Cabral R; Branco CC; Mota-Vieira L
    Mol Diagn Ther; 2009; 13(4):261-8. PubMed ID: 19712005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occupational bladder cancer: Polymorphisms of xenobiotic metabolizing enzymes, exposures, and prognosis.
    Lukas C; Selinski S; Prager HM; Blaszkewicz M; Hengstler JG; Golka K
    J Toxicol Environ Health A; 2017; 80(7-8):439-452. PubMed ID: 28696839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.